Inventor · disambiguated record
Sean O'Brien
Also filed as: O'BRIEN SEAN · O'BRIEN SEAN E
1 granted patent·10 pending applications·5 citations·filing 2003–2024
25Inventor score
Files withCYLENE PHARMACEUTICALS INC2DRYGIN DENIS2AVALON PHARMACEUTICALS1HADDACH MUSTAPHA1O'BRIEN SEAN1
Top patents by PatentIndex Score
11 records- 0167US2024317727A1Compositions and methods for the treatment of cancerUNIV DUKE·Filed 2024·Application pending·0 cites
- 0265US7094791B2Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereofAVALON PHARMACEUTICALS·Filed 2003·Granted Aug 22, 2006·5 cites·22 claims
- 0359US2008318939A1Methods for treating ophthalmic disordersWHITTEN JEFFREY P·Filed 2008·Application pending·0 cites
- 0454US2009181377A1HUMAN RIBOSOMAL DNA (rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOFCYLENE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0550US2007117770A1Human ribosomal DNA (rDNA) and ribosomal RNA (rRNA) nucleic acids and uses thereofCYLENE PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 0649US2008318938A1Methods for treating aberrant cell proliferation disordersRYCKMAN DAVID M·Filed 2008·Application pending·0 cites
- 0747US2009291437A1Methods for targeting quadruplex sequencesO'BRIEN SEAN·Filed 2006·Application pending·0 cites
- 0836US2005032794A1Diamine derivatives of quinone and uses thereofFiled 2004·Application pending·0 cites
- 0927US2010267753A1Methods of treating disorders associated with protein kinase ck2 activityHADDACH MUSTAPHA·Filed 2010·Application pending·0 cites
- 1027US2011212845A1Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 InhibitorsDRYGIN DENIS·Filed 2010·Application pending·0 cites
- 1121US2010173013A1Treatment of neoplastic disorders using combination therapiesDRYGIN DENIS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sean O'Brien files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →